You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
23 March 2026 - PANTHERx Rare Pharmacy, a specialty pharmacy focused on rare and orphan diseases, announced on Friday that it has ben selected by biopharmaceutical company Rhythm Pharmaceuticals Inc (Nasdaq:RYTM) as the exclusive US pharmacy distribu...
23 March 2026 - Chinese biopharmaceutical company Dizal (SSE:688192) announced on Saturday that its multinational Phase 3 WU-KONG28 study evaluating ZEGFROVY (sunvozertinib) monotherapy as first-line treatment in non-small cell lung cancer (NSCLC) wi...
20 March 2026 - Clinical-stage biotechnology company Synnovation Therapeutics LLC announced on Friday that Swiss pharmaceutical company Novartis AG (SIX:NOVN) (NYSE:NVS) has agreed to acquire Pikavation Therapeutics, a subsidiary of Synnovation, incl...
20 March 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) announced on Friday that it has signed a contract with Australian biopharmaceutical company Telix Pharmaceuticals Limited (ASX:TLX, NASD...
20 March 2026 - Bambusa Therapeutics Inc, a clinical-stage biotechnology company developing next-generation bispecific antibodies for immunology and inflammation (I&I), announced on Thursday the appointment of Todd James as executive vice preside...
20 March 2026 - Collegium Pharmaceutical Inc (Nasdaq:COLL) and Corium Therapeutics Holdings LLC announced on Thursday a definitive agreement for Collegium to acquire AZSTARYS for USD650m in cash with the potential for additional milestone payments up...
19 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) on Thursday announced positive topline results from the Phase 3 TALAPRO-3 study evaluating TALZENNA (talazoparib) in combination with XTANDI (enzalutamide) in patients with homologous...